David Zhang graduated in Computer Science from Peking University. He received his MSc in 1982 and his PhD in 1985 in both Computer Science from the Harbin Institute of Technology (HIT), respectively. From 1986 to 1988 he was a Postdoctoral Fellow at Tsinghua University and then an Associate Professor at the Academia Sinica, Beijing. In 1994 he received his second PhD in Electrical and Computer Engineering from the University of Waterloo, Ontario, Canada. He has been a Chair Professor at the Hong Kong Polytechnic University where he is the Founding Director of Biometrics Research Centre (UGC/CRC) supported by the Hong Kong SAR Government since 2005. Currently, he is Presidential Chair Professor in Chinese University of Hong Kong (Shenzhen). He also serves as Visiting Chair Professor in Tsinghua University and HIT, and Adjunct Professor in Shanghai Jiao Tong University, Peking University, National University of Defense Technology and the University of Waterloo. He is the Founder and Editor-in-Chief, International Journal of Image and Graphics (IJIG); Book Editor, Springer International Series on Biometrics (KISB); Organizer, the first International Conference on Biometrics Authentication (ICBA); Associate Editor of more than ten international journals including IEEE Transactions and so on. Over past 30 years, he have been working on pattern recognition, image processing and biometrics, where many research results have been awarded and some created directions, including palmprint recognition, computerized TCM and facial beauty analysis, are famous in the world. So far, he has published over 20 monographs, 400 international journal papers and 40 patents from USA/Japan/HK/China. He has been continuously listed as a Highly Cited Researchers in Engineering by Clarivate Analytics (formerly known as Thomson Reuters) in 2014, 2015, 2016, 2017, 2018 and 2019, respectively (http://highlycited.com). He is also ranked 80 with H-Index 115 at Top 1000 Scientists for international Computer Science and Electronics (http://www.guide2research.com/scientists). Professor Zhang is a Croucher Senior Research Fellow, Distinguished Speaker of the IEEE Computer Society, and an IEEE Life Fellow and IAPR Fellow.

Ge Wang is Clark & Crossan Endowed Chair Professor and Director of Biomedical Imaging Center, Rensselaer Polytechnic Institute, Troy, NY, USA. He published the first spiral cone-beam CT paper in 1990s and since then many papers systematically contributed to theory, algorithms, artifact reduction and biomedical applications in this important area. Currently, there are ~200 million medical CT scans yearly with a majority in the spiral/helical cone-beam/multi-slice mode. His group and collaborators developed interior tomography to solve the long-standing “interior problem” for high-fidelity local reconstruction, and proposed omni-tomography (“all-in-one” and “all-at-once”) with CT-MRI as an example. He initiated bioluminescence tomography as a new molecular imaging modality. He wrote the first perspective on deep-learning-based tomographic imaging in 2016 as the new frontier of machine learning, 2 papers on deep imaging in Nature Machine Intelligence, and a textbook on this topic with his coauthors published by IOP in 2019. He wrote over 500 journal papers and 100 issued and pending patents, receiving a high number of citations and academic recognitions/awards. His results were featured in Nature, Science, PNAS, and news media. His team has been continuously and strongly funded by federal agencies and companies. His main interest is in medical imaging and artificial intelligence. He is Outstanding Associate Editor of IEEE Transactions on Medical Imaging and Lead Guest Editor of 6 special issues for this flagship journal. He is Fellow of IEEE, SPIE, OSA, AIMBE, AAPM, AAAS, and National Academy of Inventors

Henryk Kalisz obtained his BSc (Hons) in Biological Sciences in 1981 and PhD in Biochemistry in 1985 at the University of Manchester. He then worked as a postdoctorate at the University of Freiburg, Germany, in the group of Prof. Helmut Holzer In 1987. He joined the National Research Institute (Gesellschaft für Biotechnologische Forschung) in Braunschweig, Germany, as Senior Scientist and Project Leader, leading a number of projects, including structure-function studies of Technical Enzymes, Trypanosomal Peroxidase System, Tyrosine Aminotransferases. In 1996 he also took up a Lectureship position at the Magdeburg Fachhochschule, Germany, lecturing final year Chemistry Diploma students on Biochemistry. In September 2001 he joined Pharmacia (Pharmacia-Pfizer and Nerviano Medical Sciences), Nerviano, Italy, as Head of Biochemistry, where he was responsible for the design, production and characterisation of proteins for structure-based drug design and for the identification of biomarkers for clinical studies. In 2007 he joined Eucodis Bioscience in Vienna, Austriaas Chief Scientific Officer and in October 2011 he formed Enzymes4Biotech in Pinner, UK, applying his expertise in industrial enzymology as a consultant and independent representative to provide scientific and technological advice and assistance to Biotechnology and Pharmaceuticals organizations. He is currently focusing is on the discovery, design and development of customised enzymes for various industrial applications, as well as the application of biocatalytic processes for the development of bio-based productsand for the (chemo-) enzymatic synthesis of pharmaceutical intermediates and APIs.He has published over 60 international scientific publications, as well as patents and book chapters.

Dr. Brian Tobin, is the CEO and Principal of "Tobin Biomedical Consultants, LLC", Executive Director and Founder of "Synergy Global Health Foundation, Inc." He has 25 years of AAMC Medical School administrative, research, clinical, and educational experience as Professor of Biomedical Science, Pediatrics and Internal Medicine. Dr. Tobin was the Founding Chair, Department of Biomedical Sciences at UofSC Medical School, Greenville SC. and served as Associate Dean for Medical Education and Founding Chair Dept of Medical Education at The Paul L. Foster School of Medicine, El Paso TX. Dr. Tobin and colleagues have founded three "New Generation" AAMC medical schools, including Mercer University School of Medicine, Savannah GA. During his 25-year career, Dr. Tobin has engaged basic medical science educators, biomedical scientists, clinicians, and allied healthcare professionals in research and patient practice where he developed interdisciplinary and interprofessional medical programs. His research in diabetes, nutrition, exercise, islet transplantation, and microgravity was funded by the NIH, NASA, ASEE, NSBRI, IBMP, and Philanthropic Research Foundations. In 2000, he served on the Executive Committee, NHLBI Nutrition Academic Award, as Editor of the NIH "Nutrition Curriculum Guide for Training Physicians." In 2003, he received the Grace Goldsmith Award from the American College of Nutrition and the Outstanding Nutrition Alumni Award from the PSU Nutrition and Dietetics Alumni Society. In 2007, he was bestowed the Presidential Award by the American College of Nutrition. Dr. Tobin presided over numerous national and international symposia for prestigious scientific societies. In 1995, he served on the Board of Directors, PSU Alumni Society, Health & Human Development, and was President 2005–2006. In 2006-2007 he served as President of the American College of Nutrition. In 2012, he was elected Scientific Councilor to the Medical Nutrition Council of the American Society for Nutrition. The following are the Professional Society memberships of Dr. Tobin : American College of Nutrition (ACN), American College of Sports Medicine (ACSM), American Diabetes Association (ADA), American Society for Nutrition (ASN), American Society for Nutritional Sciences (ASNS), American Society for Clinical Nutrition (ASCN), Canadian Diabetes Association (CDA), International Association for Medical Science Education (IAMSE), International Pancreatic Islet Transplant Association (IPITA).

Dr. Luis Antonio Pando Orellana qualifications include Doctor in Chemical Biological Sciences, Instituto Politécnico Nacional, 2017, Thesis: Protein S100B as an early marker of brain damage in pediatric congenital heart disease population, Expert in Neuropsychiatry for the Mexico City Superior Court of Justice, 1992-1998 and, starting July 2013, the Pediatric area is included, Mexican Council of Certification in Pediatrics, A.C., 2002, Specialty in Legal and Forensic Medicine by the Mexican Council of Legal and Forensic Medicine, A.C., 2001, Specialist in Inmunology from the National School of Sciences, Instituto Politécnico Nacional, 1980-1984, Doctoral examination in August 2015, Certificate as Neurologist and Psychiatrist by the American Board of Medical Specialties, 1996, Resident in the National Institute of Cardiology Ignacio Chávez, 1979, Specialty in Neuropsychiatry, Hospital Español de México, Mexican Council of Psychiatry, A.C. (C.P. AECM-31878), 1977-1979, Scientific invitation from the Canadian International Development Agency, McMaster University, Faculty of Health Sciences, Canada, 1978, Certificate as MD by the Texas Medical Board in Medicine, 1976-1977. Certificate of Proficiency in The Basic Sciences, State of Texas, USA, 1976, Certification by the Educational Council for Foreign Medical Graduates, 1974. Medical Doctor, Universidad Nacional Autónoma de México, 1970-1975 (C.P. 403039). Dr. Pando Experiences are as follows: Clinical researcher working on biological markers predictors of cerebral damage in congenital cardiopathies in Cardiopedriatics, National Institute of Cardiology Ignacio Chávez (INCICh), IPN, 2009 – up to date. (Doctor in Chemical Biological Sciences, Thesis: Protein S100B, 2017). Founder and General Director of the Center for Cerebral Damage (CPALC), from 1982 to the present. Pediatric ATLS, ACLS and Adult ACLS. Invited professor at the Johns Hopkins University, Baltimore, Maryland, USA, 2005. (Invited scientist, Faculty of Medicine, Inmunogenetics and Pediatric Neurology Department). Case presentations and laboratory activities (Sue Leffell). Professor of the Medical Psychology and Humanistic Medicine Department, Faculty of Medicine, UNAM, 2000-2003. Head of the Biomedical Engineering Seminar for 7 years at the UIA, 1992-1999. Professional exchange at the Mclean Hospital, Harvard, Massachussets, USA, with Dr. Ross Baldesarini´s case (world leader psycopharmacologist) regarding a patient treated by both of us. Head of the Neuropsychiatry and Toxicology Department of the Torre Médica Group, 1994. Head of the Neuropsychiatry Specialty, Florida-Satélite Clinic, 1987-1992. Researcher and advisor for the CEO of the Dr. Federico Gómez Children Hospital, 1987-1989. Head of the Adolescent Medicine and Neuropsychiatry Department, Federico Gómez Children Hospital, 1987-1989. Advisor on health issues for the Health Sector of Yucatán State during Lic. Víctor Manzanilla Schaffer management as gobernor. Coordinator of the Experimental and Research Area, Biomedical Unit, Faculty of Psychology, Universidad Autónoma del Estado de Morelos, 1983. Head of the Medicine Department, Lanzagorta Internacional, 1982. Researcher in Inmunology, IPN-ENCB, 1980-1984. Scholar doctor of The Hague Human Rights Jesuit Foundation assigned to the Bachajón Mission, Chilón Chiapas and Selva Lacandona as physician for the Tzéltal population medical attention. The Selva Lacandona Diary and Therapeutic Manual For Rural Communities was published by the Social and Behavior Sciences Department, ENEP IZTACALA, UNAM, 1977. Head of the Communitary Medicine Research Area, ENEP IZTACALA, UNAM, 1976- 1977. Professor of Medical Therapeutics, ULA, 2015. Head of Medical Psychology, Psychiatry and Mental Health Department, UNAM, 2000-2003. Professor of Forensic Medicine, Faculty of Law, UNAM, 1996-1997. Professor of the Biomedical Engineering Seminar at the Universidad Iberoamericana, 1992-1999. Professor of Human Communication Seminar, Language Pathology Seminar, Non- verbal Communication Seminar, and Special Clinical Conditions in Learning Problems, Universidad de las Américas, A.C., 1994. Professor of the course: Interview Technique with the Psychocommunity Method from the Psychology Department, Universidad Iberoamericana, 1988. Professor of Health and Tertiary Economic Activity Module from the Medical Career, Universidad Autónoma Metropolitana, 1980. Psychiatry and Humanistic Medicine professorship, School of Medicine, Universidad La Salle, A.C., 1979. Coordinator of Biomedical Investigation, Universidad Autónoma del Estado de Morelos, 1983. Professor of Psychology, Mexican American School, 1972. Dr. Pando attended conferences: National Congresses of Neurology and Psychiatry, last 10 years, President of the V Congress of AMCATH on The Futures of México, Morelos, 2013, PsicoHabana, as speaker and president of the Temporal Lobe Epilepsy Symposium, Cuba, 2000, Dissection course of the temporal lobe, Neurosurgery, Cleveland Foundation, Washington, D.C., USA, 1999, 152 Annual Meeting of the American Psychiatric Association, Washington, D.C., USA, 1999, XX Annual Meeting of the Mexican Academy of Neurology, Jalisco, 1996, 20th International Epilepsy Congress, Oslo, Norway, 1993, Organizer of the International Seminar on Brain Damage, VAEM, CPALC, Clínica Florida Satélite, Hospital Infantil de México, McMaster University, New York University, UNAM, 1989, IV Congress of Resident Doctors and Former Residents. Advances in Pediatrics. Instituto Nacional de Pediatría, 1985. Dr. Pando published many papers. Media: collaborations or interventions are as follows: “Foro TV.” Televisa, 2010-2011, “Medical guidance programs.” Televisión Azteca, 2010, “Medical guidance programs.” Televisa, 1970-2000, “La Razón,” several interviews. Televisa,“Someone cares about you.” Testimony of gratitude. TV serie. Channel 9, Televisa, 1986-1990, “Have fun with your doctor.” Radio program, Group IMER, 1999, “Multiple articles of medical diffusion.” Revista Dimensión (Civil Engineers´ Society), 2007-2015, “Letters.” Revista Proceso, “Echo diagnosis.” Hewlett-Packard teleconference, Hospital ABC and Medical Association of the American British Cowdray Hospital, 1991. Candidacies and medical acknowledgements : Candidate for the National Prize for Clinical Research by the Iberoamerican Universities System for the Award for Medical Trajectory by the Tecnológico de Monterrey, 1997, Candidate for the Guggenheim Scholarship, 2009, Candidate for the National Prize of Public Administration, 1997, Clinical researcher, Cardiopediatrics. National Institute of Cardiology, 2011, Expert in Neuropsychiatry and Immunology. Superior Court of Justice, 1990-2000 / 2013 - , Honorary Professor of the Academy of Neurosciences of Cuba, 1998, Second place at the Clinical Research National Award. Jorge Rosencraz Foundation, 1995. Publication. Associations and Partnerships : Mexican Association of Psychiatry, 1979 –, Mexican Academy of Neurology, 1984 –, Medical Association of the Hospital Angeles del Pedregal, 1986 –, Medical Association of the Hospital Infantil de México, 1988 –, Hispanic-Mexican Association of Physicians, Hospital Español, 1988 –, Medical Association of the Hospital Infantil Privado, 1989 –, American Society of Neuroimaging, 1994 –, Association of Psychiatry and Psychotherapy of the State of México, 1994 –, Academy of Sciences of New York, 1995 –, Medical Association of Caribe (AMECA), Caribbean Medical Association, (CMA), 1997 –, Mexican Association of Thanatology, 1997 –, College of Medical Surgeons of the Mexican Republic, 2000 -, Medical Society of the Star Médica Group, 2008 –, Association of Specialists in Congenital Malformations of the Heart, 2010 -.

Dr. Jinlian Hu educated in textile engineering and materials and received Ph.D. from Manchester University, Professor Jinlian Hu is a faculty in the Department of Biomedical Engineering of the City University of Hong Kong and leads a Laboratory of Wearable Materials for Healthcare. She is a renowned scientist with industrial impact due to her unparalleled original academic research in smart materials for biomedical and textile applications. Professor Hu is a Fellow of the Royal Society of Chemistry, Hong Kong Institution of Textile and Apparel, and the Textile Institute headquartered in the UK. She is the founding chairman of the Hong Kong Wellness Science and Technology Park, an executive vice-chairman of the Hong Kong Invention and Innovation Federation.

Dr. Joseph Curtis is the Founder and Chief Scientific Officer of BioQuant Labs and works with entrepreneurial firms developing biomedical systems to participate in the digital health revolution. Participating in IBM’s Global Entrepreneur program, Curtis was successful in integrating an intelligent genomic diagnostic platform incorporating big data analytics, cloud storage and cognitive computing capability, this was one of IBMs initial forays into evaluating the potential of digital health platforms. Later, the Economist Magazine recognized Curtis and invited him to contribute to their discussions on the future of genomic medicine. As a biomedical technology management executive, Curtis completed the Siemens Diagnostics Executive Management Program and served on NIST’s Board of Examiners for Performance Excellence. He is also a Lean six-sigma Champion and his teams have realized over $30 million in cost savings for a nation-wide supplier of cellular therapies and diagnostic reagents generating $2 billion annually. During Joseph’s twenty-five-year career he has held several executive positions in government, non-profit and entrepreneurial firms. He has provided program management support for over $300 million in investments into technological innovations across the biomedical technology innovation ecosystem. This includes: regenerative medicine, manufacturing blood plasma derivatives and cellular therapies for tissue engineering, integrating digital diagnostic imaging systems for combat casualty care, introducing medical lasers for vision correction into the U.S. marketplace, and developing molecular diagnostics to identify blood-borne pathogens, select agents and emerging infectious diseases. As a biomedical systems engineer, Curtis assisted medical devices manufacturers to obtain market clearance for their products in the U.S., Canada and Japan. Curtis received his Ph.D. in Cell & Developmental Biology, from the University of California, Davis and conducted post-doctoral research at the National Cancer Institute.

Professor Sabu Thomas is currently Vice Chancellor of Mahatma Gandhi University, Kottayam, Kerala, India. Prof. Thomas is an outstanding leader with sustained international acclaims for his work in Nanoscience, Polymer Science and Engineering, Polymer Nanocomposites, Elastomers, Polymer Blends, Interpenetrating Polymer Networks, Polymer Membranes, Green Composites and Nanocomposites, Nanomedicine and Green Nanotechnology. In collaboration with India’s premier tyre company, Apollo Tyres, Professor Thomas’s group invented new high performance barrier rubber nanocomposite membranes for inner tubes and inner liners for tyres. Professor Thomas has received more than 30 national and international awards which include, FRSC, Distinguished Professorship from Josef Stefan Institute, Slovenia, MRSI medal,CRSI medal, Distinguished Faculty Award, Dr. APJ Abdul Kalam Award for Scientific Excellence – 2016,Mahatma Gandhi University- Award for Outstanding Contribution –Nov. 2016, Lifetime Achievement Award of the Malaysian Polymer Group, Sukumar Maithy Award Faculty Research Award, Trila – Academician of The Year, European Academy of Sciences He is in the list of most productive researchers in India and holds a position of No.5. Prof. Thomas has been conferred Honoris Causa (D.Sc) by the University of South Brittany, Lorient, France, Siberian Federal University, Russia and University of Lorraine, Nancy, France, awarded Senior Fulbright Fellowship, National Education Leadership Award – 2017 for Excellence in Education. Prof Thomas also won 6th contest of "mega-grants" - Russian Federation. Professor Thomas has published over 1200 peer reviewed research papers, reviews and book chapters. He has co-edited 140 books inventor of 15 patents. The H index of Prof. Thomas is 107 and has more than 54,000 citations. Prof. Thomas has delivered over 350 Plenary/Inaugural and Invited lectures in national/international meetings over 30 countries. Prof. Thomas has supervised 115 PhD programme and his students occupy leading positions in academia and industry in India and abroad.

Dr. Temple Smith obtained his PhD in Nuclear Physics from the University of Colorado in 1969, followed byan NIH (USA) postdoctoral fellowship under the direction of the mathematician, Stanislaw Ulam, and the molecular biologist, John R. Sadler. Dr. Smith is one of the founders of GenBank, initially at Los Alamos National Laboratory, and the co-developer, with Michael Waterman, of the Smith-Waterman sequence alignment algorithm. Beginning in 1988, Dr. Smith organized the “Genes and Machines” conference series in bioinformatics. As director of the Boston University BioMolecular Engineering Research Center, he directed the research of over twenty Post doctoral and graduate students. That research focused on protein evolution of: the WD-repeat family; the Life Guard apoptotic regulatory family; the evolutionary of the Drosophila clade, and the origin and evolutionary of the genetic translation system. He is a follow of the American Association for the Advancement of Science (AAAS), and a fellow of the ISCB. He has 200 plus reviewed scientific publications. In 2011 Dr. Smith was elected Emeritus Professor of BioMedical Engineering at Boston University. Dr. Smith is an avid skier, ice climber, sailor, hockey coach and family man. He is also the co-founder of a gene engineering company, Modular Genetics.

Javier Ortega-Garcia received the M.Sc. degree in electrical engineering (Ingeniero de Telecomunicacion), in 1989; and the Ph.D. degree "cum laude" also in electrical engineering (Doctor Ingeniero de Telecomunicacion), in 1996, both from Universidad Politecnica de Madrid, Spain. Dr. Ortega-Garcia is founder and co-director of the Biometric Recognition Group - ATVS. He is currently a Full Professor at the Escuela Politecnica Superior, Universidad Autonoma de Madrid, where he teaches Digital Signal Processing and Speech Processing courses. He also holds a Masters Degree course in Biometrics. His research interests are focused on biometrics signal processing: on-line signature verification, speaker recognition, web-based biometrics, data fusion and multibiometrics. He has published over 150 international contributions, including book chapters, refereed journal and conference papers. He chaired "Odyssey-04, The Speaker Recognition Workshop", "ICB-09, the 3rd IAPR International Conference on Biometrics" and "ICB-2013, the 6th IAPR International Conference on Biometrics".

Dr. Ng is a professor at the Nanyang Technological University, Singapore. He received his PhD on Engineering from the University of Cambridge. He is a Fellow of the American Society of Mechanical Engineers (FASME), FIET (UK), FIETI (HK). He is Editor-in-Chief for 2 ISI-journals which were captured by the JCR within 2-years of their inauguration. Dr. Ng has authored more than 400 publications in various journals and 14 books. His publications reflect his research interests in the field of infrared physics & technology in BME research. He has been recognized internationally for academic excellence. He was awarded the SPRING-Singapore Merit Award for his work in thermal imagers to screen SARS fever as well as contributions to the Singapore Standardization Program.

Maia Angelova is a Professor of Data Analytics and Machine Learning and Director of Data to Intelligence (D2I) Research Centre and Data Analytics Research Lab (DARL) at the School of IT at Deakin University, Melbourne Burwood Campus. She was a Professor of Mathematical Physics at Northumbria University at Newcastle upon Tyne UK from 2004 to 2016, and a Lecturer in Physics in Somerville College at Oxford Universities from 1991 to 1996. Maia’s research interests are in data-driven modelling of complex systems specifically in health and for decision making, such as models of sleep and insomnia, diabetes and glucose-insulin regulation, stress and depression, healthy ageing. She has strong expertise in time series and spectral analysis, as well as dynamical systemsfor physical, life and social systems. She also uses symmetry methods and is an expert in structures and properties of materials – carbon-based and magnetic materials, quantum optics and quantum control. Maia’s research is at the boundary between theory and applications and she is increasingly interested in translational research into the areas of health, medicine and health care.

James H. Adair is a Professor of Materials Science and Engineering, Bioengineering and Pharmacology at The Pennsylvania State University. His research and teaching interests most recently include biological-nanoscale composite particulates for nanomedical applications, based on colloid and interfacial chemistry, and material chemistry. Dr. Adair received his B.S. in Chemistry (1975) and M.S. (1979) and Ph.D. (1981) in Materials Science and Engineering, all from the University of Florida. From 1981-1982, he was a Fulbright Post-Doctoral Fellow at the University of Western Australia at the Royal Perth Hospital where he studied the biophysical chemistry origin of pathological biomineralization. From 1982 to 1997, Dr. Adair held a variety of professional positions including principal research scientist at Battelle Memorial Institute, research associate at the Materials Research Lab at Penn State, and associate professor at the University of Florida. He has been at Penn State as a Professor of Materials Science and Engineering, Biomedical Engineering, and Pharmacology since 1998. In 2005, he co-founded Pendrea Pharmaceutical, Inc. originally as Keystone Nano, Inc.) and currently serves on the Board of Directors and chief science officer. Dr. Adair is the author/co-author of about 300 publications including over 260 papers, more than 28 US and foreign patents and co-editor of 12 books including the Handbook of Characterization Techniques for the Solid-Solution Interface. Dr. Adair is a Fellow of the American Ceramic Society and the World Academy of Ceramics. He has served in multiple capacities in the American Ceramic Society at the local and national levels. In 2017, he was one of six Faculty Scholar Medal awardees and named as the 2018 Inventor of the Year in the Penn State University System. In 2020, Dr. Adair received the the Frontiers of Science and Society - Rustum Roy Lecture Award at the Annual Meeting of the American Ceramic Society.

Dr Peter Simon Sapaty, Chief Research Scientist, Ukrainian Academy of Sciences, is with networked systems for five decades. Outside of Ukraine, worked in the former Czechoslovakia (now Slovak Republic), Germany, the UK, Canada, and Japan as a group leader, deputy director of international AI lab, Alexander von Humboldt researcher, and special invited and visiting professor. He launched and chaired a SIG on Mobile Cooperative Technologies in Distributed Interactive Simulation project in the US, invented a distributed control technology that resulted in a European patent and five books with Wiley, Springer, and Emerald. He has published more than 220 papers on distributed networked systems, has been included in the Marquis Who’s Who in the World and Cambridge Outstanding Intellectuals of the 21st Century. and also works with several international scientific journals.

Bing-Huei Chen, male, food scientist, received his Ph.D. degree in Food Science & Technology, Texas A & M University, USA in 1988. His postgraduate career includes working at Fu Jen University, Taipei, Taiwan as Associate Professor from 1988–1994, Professor from 1994–2004, Distinguished Chair Professor from 2003–present, Chair of Department of Nutrition and Food Science from 1994-2000, Director of Graduate Institute of Medicine from 2006–2009, and Dean of College of Human Ecology from 2012–2015. He specializes in Lipid Chemistry, Pigment Chemistry, Instrumental Analysis, Food Toxicology, Functional Food and Botanical Drug Development and Biological Activity Determination as well as Nanotechnology. Until now he has published 193 research articles in internationally renowned journals and authored 11 book chapters in edited books published by International Publishers. He has received numerous awards including the prestigious National Invention Gold Medal Award by Ministry of Economics, Taiwan in 2018 and was honored with Outstanding Research Scientist by Ministry of Science and Technology, Taiwan. He was also honored with International Outstanding Inventor of Biotechnology by Taiwan Outstanding Inventor Association/International Innovation and Invention Alliance Association in 2019 and Distinguished Professor by Chinese Academy of Agricultural Sciences, China in 2015. Most importantly, Prof.Chen has developed a nano-product “Lycopene Chylomicron”, which has completed a phase III clinical trial in both Taiwan and USA in 2017 and demonstrated to be effective in the treatment of patients with prostatauxe syndrome. Expectedly, this product will become the first botanic drug in the world for treatment of patients with prostatauxe syndrome without side effect. More recently, the International Association of Advanced Materials (IAAM), a European organization has honored him with IAAM Scientist Award 2020 for his contribution to the advancement of science and technology. He also serves as Editor-in-Chiefof the journal “Recent Patents on Food, Nutrition and Agriculture” and Associate Editor of 2 journals “Journal of Food & Drug Analysis” and “Asian Science Bulletin”. In addition, he serves on the editorial board of 135 journals. Currently he is the President of Professors Association, Taiwan and was the Past President of AOAC Taiwan section from 2016-2018.

Prof. Xiangwei Zhao graduated from Zhejiang University with Ph.D. degree in 2006 and currently he is the deputy director of State Key Laboratory of Bioelectronics and professor of the School of Biological Science and Medical Engineering of Southeast University. He has worked as visiting scholar at Harvard Medical School, University of Illinois Urbana-Champaign, University of Michigan, and Osaka University respectively. He is also an editorial board member of Electronics and Nanophotonics. His research interests include single cell sequencing, brain organoid, point of care testing (POCT) and BioCMOS/MEMS.

Emi Yuda received a Ph.D. degree in Nihon University and a D.Eng. degree in Niigata University, Japan. From 2013 to 2014, she was a research assistant at Santa Monica College in California, USA. From 2015 to 2019, she was a NEDO project researcher at the Graduate School of Medicine, Nagoya City University. From 2019 to 2020, she was an assistant professor at the Graduate School of Engineering, Tohoku University. She has been an assistant professor at the Center for Data Driven Science and Artificial Intelligence, Tohoku University since 2020. Her current research is medical informatics, data science, and bio-signal processing. She has made many achievements in the fields of informatics and big data. IEEE senior member.

Dr. Yong-gyun Jung currently working as a Chief Technology Officer at Ezdiatech lnc. From March 2018 in 1513, 66, Beolmal-ro, Donggan-gu, Anyang-si, Gyeonggi-do, South Korea. He worked as a Assistant Professor (head of department) at Interdisciplinary Program of Biomodulation, College of Natural Science, Myongji University, Korea from September 2016 - February 2018. Dr. Jung was the Director of Research in Quantamatrix lnc, Seoul National University Hospital, Daehak-ro 71, Jongro-gu, Seoul, Korea from March 2011- August 2016. Dr. Jung completed his Ph.D. at Laboratory of Prof Mark Buttner, Department of Molecular Microbiology, John Innes Centre, Norwich, UK in 2007. Dr. Jung received awards as follows : Achievement award for the 50th Korean National Tuberculosis Association anniversary, 2013, Federation of European Microbiological Society (FEMS) Young Scientists Meeting Grant for the 10th International Symposium on the Genetics of Industrial Microorganisms, 2006, Grant from the Science and Technology Policy Institute of Korea for the 9th International Symposium on the Genetics of Industrial Microorganisms, 2002, Grant from Education’s Brain Korea 21 Project for the 12th International Symposium on the Biology of Actinomycetes (ISBA), 2001, Myongji University Presidental award for the highest degree score in the College of Natural Science, 2000. Dr. Jung attended many conferences as a Oral presenter and poster presenter as follows: Annual International Meeting of the Microbiological Society of Korea, Jeonju-si, Korea (May 2013), 48th Microbiological Society of Korea Anniversary International Symposium on Microbiology (May 2008), 33nd Annual Meeting of Korean Scientists and Engineers’ association in the UK, University of Edinburgh, UK (June 2007), 32nd Annual Meeting of Korean Scientists and Engineers’ association in the UK, University of College London, UK (November 2006), 115th General meeting of American Society for Microbiology (ASM) 2015, New Orleans, USA (May 2015), Annual International Meeting of the Microbiological Society of Korea, Changwon, Korea (April 2015), 32nd World Congress of Internal Medicine (WCIM) 2014, Seoul, Korea (October 2014), 114th General meeting of American Society for Microbiology (ASM) 2014, Boston, USA (May 2014), Annual International Meeting of the Microbiological Society of Korea, Daegu, Korea (April 2014), Annual International Meeting of the Microbiological Society of Korea, Jeonju-si, Korea (May 2012), 14th The Korean MEMS conference, Chejudo, Korea (April 2012), 1st Annual Meeting of Society for Laboratory Automation and Screening (SLAS) 2012, San Diego, USA (February 2012), Annual Meeting of Biochip 2011 society, Ulsan, Korea (November 2011), 15th International Symposium on the Biology of Actinomycetes (August 2009), 50th Microbiological Society of Korea Anniversary International Symposium on Microbiology (May 2009), Annual Science Meeting 2006, Norwich, U.K. (October 2006) , 10th International Symposium on the Genetics of Industrial Microorganisms, Prague, Czech Republic (June 2006), Streptomyces functional genomics Dissemination meeting, John Innes Centre, Norwich, U.K. (January, 2006), Annual Science Meeting 2005, Norwich, U.K. (October 2005), 9th International Symposium on the Genetics of Industrial Microorganisms, Gyeonju, Korea (July 2002), Meeting of the Korean Society for Microbiology and Bioengineering, Seoul, Korea (October 2002), International Meeting of the Microbiological Society of Korea (Recent Progress in Microbial Ecology and Pathogenesis), Seoul, Korea (November 2001), 12th International Symposium on the Biology of Actinomycetes, Vancouver, Canada (August 2001), Meeting of the Korean Society for Industrial Microbiology (New Horizons in Microbiology and Biotechnology), Chungcheongdo, Korea (June 2001).

Oscar Casanova (Electronic Engineering, MBA and PhD in Biomedical Engineering), is Professor at the Rey Juan Carlos University and Carlos III University of Madrid of the Department of Electronic Technology. Researcher at the Center for Biomedical Technology of the Polytechnic University of Madrid in the area of Nanomedicine, in-vitro and in-vivo experimentation since 2014. His research focuses on anticancer optic and magnetic hyperthermia therapies. He has participated directly in projects of the National Research Plan of Spain, and as well as of the European Union. Currently he also works as a Biomedical Applications Development Engineer at Vanyan Solutions SL in Madrid Spain. He was a professor since 2006 at the Simon Bolivar University in Caracas Venezuela and a researcher in Medical Signs and Images. Professor and researcher in bioengineering and electromedicine at the University of Táchira - Venezuela until 2013.

Dr. Eirini Marouli is a Lecturer in Computational Biology at the William Harvey Research Institute, Queen Mary University of London. Dr Marouli’s research interests lie in the interface of genetics, machine learning and bioinformatics, in order to achieve a better understanding of human biology and disease prediction with the use of “Big Data”. Dr Marouli has a leading role in the large international consortium, GIANT, that has discovered almost all of the genetic variants that are known to influence human height and obesity related traits. Dr Marouli has also a leading work and contributions in global consortia (GLGC, CHARGE CARDIoGRAMplusC4D) for complex traits and diseases. In addition to gene discovery efforts, Dr Marouli is also interested in genetic-epigenetic approaches to complex phenotypes. Dr Marouli specialises on Mendelian Randomisation and causal inference and is a co-convener of the Mendelian Randomisation working group within GIANT consortium. Dr Marouli’s research is also focusing on thyroid function and disease in collaboration with ThyroidOmics consortium. Dr Marouli is passionate about applications of Artificial Intelligence for disease prediction.

Dr. Naser is currently a research scientist in the Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA. He received his PhD in Engineering Physics from McMaster University, Hamilton, ON, Canada in 2010 and his MSc in Engineering Physics in 2005 and his BSc in Electronics and Communications Engineering in 2000 from Cairo University, Egypt. He has been working as an assistant Professor in the Department of Electrical Engineering, King Faisal University, Saudi Arabia (2014/2016) and as a visiting assistant professor in the Department of Electronics and Computer Engineering, McMaster University, Canada for multiple times. His current research focuses on Machine and deep learning (DL) approaches for developing MRI-based imaging biomarkers that correlate with tumor response and normal tissue toxicity that can be utilized for outcome predictions for head and neck cancer (HNC) patients for adaptive radiotherapy planning. His previous research work focused on developing inverse models for quantitative optical and photoacoustic functional and molecular imaging in small animal model for preclinical applications. In addition to his work in biomedical imaging, Dr. Naser’s PhD work was focused in developing theoretical models for electrical and optical characterization and design optimization of semiconductor self-assembled quantum photodetectors for medical and environmental sensing applications.

Dr. Yong Lei received his Bachelors’ degree from Wuhan University, China. He earned his Ph.D. in Biomedical Sciences at The Chinese University of Hong Kong in 2013, carrying out genome editing strategies (ZFNs, TALENs, CRISPR) to construct animal models in studying early embryogenesis. As a pioneer researcher achieving targeted genome editing in vivo, his paper was cited by Science as Ten Breakthroughs of 2012. He then joined the lab of renowned hematologist Prof. Margaret A. Goodell at Baylor College of Medicine for postdoc training, focusing on DNA hypermethylation editing and the role of aberrant DNA methylation in leukemogenesis. Applying the state-of-the-art methylation editing technique, he published the first study on targeted hypermethylation in mice zygote worldwide. In June 2020, he joined the School of Life and Health Sciences at The Chinese University of Hong Kong (Shenzhen) as an Assistant Professor. His research interests include deterioration of epigenome proof-reading system in ageing and its role in re-sculpturing epigenetic marks, and the maintenance of induced DNA hypermethylation through intergenerational inheritance. He has published multiple papers in high-impact journals, including Nature Genetics, Genome Biology, Nature Communications, Nucleic Acids Research and PNAS.

I officially got my Ph.D. in Biological Sciences from Tokyo Metropolitan University when she was a Junior Researcher in RIKEN, Japan from 8/2012-3/2017. After graduation, I moved to Korea and worked as a Research Professor at Korea University from 7/2017-7/2020, and subsequently work as a research scientist at Friedrich-Alexander-University of Erlangen-Nürnberg, Institute of Fluid Mechanics (LSTM) Busan. Our group focuses on development aptamer-based device for detection contaminant in food samples and development SELEX for selection aptamer in biological and medical processes concerning cancer therapy in all its forms. Also, Iam a one of the co-founders for Innovative Bioscience Group.